Guybro Animal Health Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.72 Cr
- Revenue Growth 0.34%
- Profit Growth 8.24%
- Ebitda 29.53%
- Net Worth 71.59%
- Total Assets 0.23%
About Guybro Animal Health
Guybro Animal Health Private Limited (GAHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 February 2014 and has a history of Ten years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Guybro Chemical Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.72 Cr.
Gaurav Bedi, Ravita Bedi, and Gautam Singh serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110MH2014PTC253378
- Company No.
253378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2014
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Guybro Animal Health?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gaurav Bedi | Director | 18-Feb-2014 | Current |
Ravita Bedi | Director | 18-Feb-2014 | Current |
Gautam Singh | Director | 18-Feb-2014 | Current |
Financial Performance of Guybro Animal Health.
Guybro Animal Health Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.34% increase. The company also saw a slight improvement in profitability, with a 8.24% increase in profit. The company's net worth Soared by an impressive increase of 71.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Guybro Animal Health?
In 2023, Guybro Animal Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.16 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.72 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
09 Aug 2023 | Axis Bank Limited | ₹1.72 Cr | Open |
How Many Employees Work at Guybro Animal Health?
Guybro Animal Health has a workforce of 28 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Guybro Animal Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Guybro Animal Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.